Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Dysfunction of a urate exporter abcg2 increases serum uric acid by decreased intestinal urate excretion
- In: Posters G - Pharmacokinetics (PK), Pharmacodynamics (PD) and Systems Pharmacology
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PG-011
- By: TAKADA, Tappei (The University of Tokyo Hospital, Department of Pharmacy, Tokyo, Japan)
- Co-author(s): Ichida, Kimiyoshi (Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan)
Matsuo, Hirotaka (National Defense Medical College, Saitama, Japan)
Nakayama, Akiyoshi (National Defense Medical College, Saitama, Japan)
Suzuki, Hiroshi (The University of Tokyo Hospital, Tokyo, Japan) - Abstract:
Background
ATP-binding cassette transporter G2 (ABCG2), also known as breast cancer resistance protein (BCRP), is identified as a high-capacity urate exporter and its dysfunction has an association with serum uric acid (SUA) levels and gout/hyperuricemia risk. However, pathophysiologically important pathway(s) responsible for the ABCG2-mediated.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023